secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2024-09-30T23:59:59+00:00
Accession:  0001437749-24-030269
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene amends loan with Avenue; Oct payment cut to $2M, interest-only period tied to equity raise and ALS NDA progress
--------------------------------------------------------------------------------

- October 2024 principal payment reduced from $3.33M to $2M.
- Interest-only period from Nov-Dec 2024 contingent on raising $10M in equity by Oct 31, 2024; $7M raised in Sep 2024.
- If FDA allows ALS NDA submission for CNM-Au8 by Dec 31, 2024, loan amortization extends to June 2025; otherwise full repayment by April 2025.
- Warrant exercise price lowered from $16.00 to $4.6014 per share for Avenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000143774924030269/0001437749-24-030269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000143774924030269/clnn20240928c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-030269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer